CARGO Therapeutics, Inc.
CARGO Therapeutics, Inc. (CRGX) is a biotechnology company focused on developing advanced therapies in the field of oncology. The company specializes in creating innovative chimeric antigen receptor T-cell (CAR-T) therapies designed to target and eliminate cancer cells. Operating within the biotechnology and healthcare sectors, CARGO Therapeutics is committed to advancing cancer treatment through cutting-edge research and clinical trials aimed at providing patients with effective and personalized therapeutic options.